| |
Solstice Neurosciences, Inc. is a specialty biopharmaceutical company focused on the development, manufacturing, sales and marketing of specialty biopharmaceutical products.
Solstice’s first product, Myobloc® (rimabotulinumtoxinB) Injection, represents the only botulinum toxin type B currently available to physicians and patients worldwide.
Privacy Policy
2009 Comprehensive Compliance
Program
| |
Myobloc®and NeuroBloc®
|
|
Myobloc® (rimabotulinumtoxinB) Injection and NeuroBloc® (Botulinum Toxin Type B) Injectable Solution are indicated for the treatment of adults with cervical dystonia to reduce the severity of abnormal head position and pain associated with cervical dystonia. Before administering MYOBLOC, physicians should consult the Important Safety Information, full Prescribing Information and Medication Guide
MYOBLOC and NeuroBloc represent the only Type B toxin currently available to physicians and patients worldwide.
For more information regarding order placement, medical information, and reimbursement services please call
1-888-461-2255.
Our trained specialists are available Monday - Friday 8am - 7pm Eastern Time.
|
|
|
| News |
Solstice Neurosciences, Inc. Issues a Corporate Response to FDA Early Communication
more>>
Dennis L. Smith appointed President and Chief Executive Officer of Solstice Neurosciences, Inc.
more>>
Solstice Neurosciences, Inc. Launches
MYOBLOC™ University
more>>
Solstice Neurosciences, Inc. Presents Escalating Dose Study at International Congress in Istanbul, Turkey
more>>
|
|
|
|
